Core Needle Biopsy Devices Market Report 2024 (Global Edition)

Global Core Needle Biopsy Devices Market Report 2024 Market Size Split by Type (Full-Automated Core Needle Biopsy Device, Semi-Automated Core Needle Biopsy Device), by Application (Hospitals, Clinics,...

Core Needle Biopsy Devices Market Report Description

We have various report editions of Core Needle Biopsy Devices Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Core Needle Biopsy Devices Market Insights Video

Competitive Landscape of the Core Needle Biopsy Device Market

The competitive landscape of the Core Needle Biopsy Device market is characterized by a diverse range of players, including established medical device manufacturers, specialized biotech companies, and emerging startups. Key industry participants are continuously investing in research and development to innovate and enhance the efficacy and safety of their products.

In Mar 2022, Hologic, Inc., an innovative medical technology company primarily focused on improving women’s health, opened its Innovation Center today in Aix-en-Provence, France. The new commercial office and training and research and development facility will support Hologic’s ultrasound, interventional, and surgical solutions across the continuum of breast health care . (Source: https://investors.hologic.com/press-releases/press-release-details/2022/Hologic-Opens-New-Innovation-Center-in-France/default.aspx) In April 2021, Unilabs and GE Healthcare signed a partnership agreement. GE Healthcare provides technically advanced MRIs and CT scanning technology, ultrasound devices, mammography, and X-ray machines to Unilabs in Portugal. (Source: https://www.gehealthcare.com/about/newsroom/press-releases/unilabs-and-ge-healthcare-launch-partnership-for-latest-radiology-equipment-and?npclid=botnpclid)

Top Companies Market Share in Core Needle Biopsy Devices Industry: (In no particular order of Rank)

• ARGON MEDICAL
• Becton Dickinson and Company
• C.R. Bard
• Inc.
• Cook Medical Inc.
• Devicor Medical Products
• Inc.
• F. Hoffmann-La Roche Ltd.
• GE Healthcare
• Hologic
• Inc.
• Leica Biosystems
• Medax Srl Unipersonale
• Planmed Oy
• Scion Medical Technologies
• LLC
• Siemens Healthier
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Core Needle Biopsy Device Market

Which Region Dominates the Core Needle Biopsy Device Market in 2024?

According to Cognitive Market Research, North America dominates the Core Needle Biopsy Device market due to several key factors. The region boasts advanced healthcare infrastructure, high prevalence of cancer, and increasing demand for minimally invasive diagnostic procedures. Technological innovations in biopsy devices, along with significant investments in research and development, further enhance market growth.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific region is the fastest-growing market for Core Needle Biopsy Devices due to several factors driving rapid expansion. Increasing incidences of cancer, particularly breast and lung cancers, have heightened the demand for effective diagnostic tools. Rapid urbanization and improving healthcare infrastructure in countries like China and India are enhancing access to advanced medical technologies.

The current report Scope analyzes Core Needle Biopsy Devices Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Core Needle Biopsy Devices

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 2741.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.4% from 2024 to 2031.

• According to Cognitive Market Research, the US had a major share in the Core Needle Biopsy Device market with a market size of USD 2163.28 million in 2024 and is projected to grow at a CAGR of 13.2% during the forecast period. The U.S. market's increasing prevalence of cancers and advancements in biopsy techniques.
• The Canada Core Needle Biopsy Device market had a market share of USD 329.02 million in 2024 and is projected to grow at a CAGR of 14.2% during the forecast period. Canada’s increasing prevalence of cancers and advancements in biopsy techniques.
• The Mexico Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 249.50 million in 2024.

Europe Core Needle Biopsy Devices

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 2056.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 13.7% from 2024 to 2031.

• The United Kingdom Core Needle Biopsy Device market had a market share of USD 345.47 million in 2024 and is projected to grow at a CAGR of 14.5% during the forecast period. In the UK, Core Needle Biopsy Device sales witness an upswing due to the owing to the growing emphasis on sustainability.
• The France Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.9% during the forecast period, with a market size of USD 189.18 million in 2024.
• According to Cognitive Market Research, the German Core Needle Biopsy Device market size was valued at USD 407.16 million in 2024 and is projected to grow at a CAGR of 13.9% during the forecast period. In Germany, Core Needle Biopsy Device surged due to the owing to the growing emphasis on sustainability.
• The Italy Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.1% during the forecast period, with a market size of USD 176.85 million in 2024.
• The Russia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.7% during the forecast period, with a market size of USD 318.73 million in 2024.
• The Spain Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.8% during the forecast period with a market size of USD 168.62 million in 2024
• The Luxembourg Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.8% during the forecast period, with a market size of USD 63.75 million in 2024.
• The Portugal Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.5% during the forecast period, with a market size of USD 43.18 million in 2024.
• The Greece Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 24.68 million in 2024.
• The Rest of Europe's Core Needle Biopsy Device market is projected to witness growth at a CAGR of 12.4% during the forecast period, with a market size of USD 318.73 million in 2024.

Asia Pacific Core Needle Biopsy Devices

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 1576.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 17.2% from 2024 to 2031.

• According to Cognitive Market Research, the China Core Needle Biopsy Device market size was valued at USD 709.44 million in 2024 and is projected to grow at a CAGR of 16.7% during the forecast period. Core Needle Biopsy Device surged in China due to increasing awareness of cancer screening.
• The Japan Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 217.56 million in 2024.
• The India Core Needle Biopsy Device market had a market share of USD 189.18 million in 2024 and is projected to grow at a CAGR of 19.0% during the forecast period. India's increasing awareness of cancer screening .
• The South Korean Core Needle Biopsy Device market is projected to witness growth at a CAGR of 16.3% during the forecast period, with a market size of USD 157.65 million in 2024.
• The Australian Core Needle Biopsy Device market is projected to witness growth at a CAGR of 16.9% during the forecast period, with a market size of USD 81.98 million in 2024.
• The South East Asia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 18.2% during the forecast period, with a market size of USD 108.78 million in 2024.
• The Rest of Asia Pacific Core Needle Biopsy Device market is projected to witness growth at a CAGR of 17.0% during the forecast period, with a market size of USD 111.93 million in 2024.

South America Core Needle Biopsy Devices

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which the Latin America held the market share of around 5% of the global revenue with a market size of USD 342.73 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.6% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Core Needle Biopsy Device market size was valued at USD 146.69 million in 2024 and is projected to grow at a CAGR of 15.2% during the forecast period. Core Needle Biopsy Devices flourished in Brazil due to increasing incidence of cancer and a rising focus on early detection and diagnosis.
• Argentina's Core Needle Biopsy Device market had a market share of USD 57.58 million in 2024 and is projected to grow at a CAGR of 15.5% during the forecast period. Argentina's increasing incidence of cancer and a rising focus on early detection and diagnosis .
• Colombia Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 30.50 million in 2024.
• Peru Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.8% during the forecast period, with a market size of USD 28.10 million in 2024.
• Chile Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.9% during the forecast period, with a market size of USD 24.68 million in 2024.
• The Rest of Latin America's Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.7% during the forecast period, with a market size of USD 55.18 million in 2024.

Middle East and Africa Core Needle Biopsy Devices

According to Cognitive Market Research, the global Core Needle Biopsy Device market size was estimated at USD 6854.5 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 137.09 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.9% from 2024 to 2031..

• The GCC Countries Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.7% during the forecast period, with a market size of USD 58.67 million in 2024. Core Needle Biopsy Device sales flourish due to the increasing cancer prevalence and a growing emphasis on diagnostic accuracy.
• The Egypt Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.2% during the forecast period, with a market size of USD 14.39 million in 2024.
• The South Africa Core Needle Biopsy Device market is projected to witness growth at a CAGR of 15.9% during the forecast period, with a market size of USD 21.66 million in 2024. Core Needle Biopsy Device sales flourished in South Africa due to increasing cancer prevalence and a growing emphasis on diagnostic accuracy.
• The Turkey Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.4% during the forecast period, with a market size of USD 11.79 million in 2024.
• The Nigeria Core Needle Biopsy Device market is projected to witness growth at a CAGR of 14.0% during the forecast period, with a market size of USD 14.39 million in 2024.
• The Rest of the MEA Core Needle Biopsy Device market is projected to witness growth at a CAGR of 13.9% during the forecast period, with a market size of USD 16.18 million in 2024.

Core Needle Biopsy Devices Market Analysis

Core Needle Biopsy Device Market Type Segment Analysis

According to Cognitive Market Research, The Full-Automated Core Needle Biopsy Device is currently the dominant category in the Core Needle Biopsy Device market. This dominance can be attributed to its enhanced efficiency and precision in performing biopsies. The automated features significantly reduce the time required for procedures, which is increasingly crucial in clinical settings where rapid diagnosis is paramount.

The Semi-Automated Core Needle Biopsy Device represents the fastest-growing category in the Core Needle Biopsy Device market. This growth is largely driven by the increasing demand for user-friendly systems that balance automation and manual intervention. Healthcare providers appreciate the flexibility offered by semi-automated devices, allowing for a degree of operator control while still benefiting from improved speed and efficiency.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Core Needle Biopsy Devices Industry. Request a Free Sample PDF!

Core Needle Biopsy Device Market Application Segment Analysis

According to Cognitive Market Research, The Core Needle Biopsy Device market is predominantly driven by its application in hospitals. Hospitals serve as the primary healthcare institutions for a significant volume of diagnostic procedures, including biopsies. The advanced infrastructure and specialized personnel in hospitals allow for the efficient utilization of core needle biopsy devices, leading to higher patient throughput.

Clinics represent the fastest-growing application category in the Core Needle Biopsy Device market. The surge in outpatient services and the increasing trend of patients seeking care in clinic settings have propelled the demand for biopsy procedures in these facilities. Clinics often provide a more accessible and less intimidating environment for patients, leading to a rise in the number of biopsies performed.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Core Needle Biopsy Devices Disease Segment Analysis

Core Needle Biopsy Device Market Disease Segment Analysis

According to Cognitive Market Research, The Breast Cancer is the dominant disease category driving demand for biopsy procedures. This prevalence is largely due to the high incidence rate of breast cancer globally, combined with increased awareness and screening initiatives that encourage early detection. Core needle biopsies are frequently utilized in breast cancer diagnosis because they are less invasive and provide accurate tissue samples, allowing for effective treatment planning.

Lung Cancer represents the fastest-growing disease category in the Core Needle Biopsy Device market. The rise in lung cancer cases, driven by factors such as smoking, environmental pollutants, and genetic predispositions, has heightened the need for precise diagnostic tools. Core needle biopsy procedures are increasingly favored for lung cancer diagnosis due to their minimally invasive nature and ability to obtain tissue samples from difficult-to-reach areas within the lungs.

• Lung Cancer
• Liver Cancer
• Breast Cancer
• Prostate Cancer

Core Needle Biopsy Devices Range Segment Analysis

Core Needle Biopsy Device Market Range Segment Analysis

According to Cognitive Market Research, The Core Needle Biopsy Device market is predominantly driven by the 14G-18G range of biopsy needles. This range is favored in clinical settings due to its versatility and effectiveness in obtaining adequate tissue samples for various diagnostic procedures. Needles within the 14G-18G category strike a balance between needle gauge and patient comfort, providing a sufficient diameter to collect sufficient tissue while minimizing trauma.

The 18G core needle biopsy devices represent the fastest-growing category in the market. The increasing preference for 18G needles is driven by their enhanced capability for collecting larger tissue samples, which is crucial for accurate histological analysis and diagnosis. As the healthcare industry shifts towards more personalized medicine and precision diagnostics, the demand for reliable and efficient biopsy techniques has surged.

• 14G- 18G
• 18G

Core Needle Biopsy Devices Distribution Channel Segment Analysis

Core Needle Biopsy Device Market Distribution Channel Segment Analysis

According to Cognitive Market Research, The direct sales emerge as the dominant distribution channel. This approach allows manufacturers to maintain close relationships with healthcare providers, ensuring a deeper understanding of their needs and preferences. Direct sales enable companies to provide tailored support and training to medical professionals, enhancing the adoption and effective use of core needle biopsy devices.

The distributor channel is recognized as the fastest-growing distribution category in the Core Needle Biopsy Device market. The growth in this area is driven by the expanding network of healthcare facilities that rely on distributors for timely access to medical devices. Distributors often have established relationships with multiple healthcare providers, enabling them to efficiently supply core needle biopsy devices to a wide range of clinics and hospitals.

• Direct Sales
• Distributor

Author's Detail

Anushka Gore

Research Associate at Cognitive Market Research

LinkedIn

Profile

Anushka Gore is a seasoned market researcher specializing in the dynamic landscape of the Pharmaceutical industry. With a keen analytical mind and a deep passion for healthcare advancements, she has dedicated herself unraveling the intricate market trends and consumer behaviors that shape the future of medical technologies and services.

Author's Conclusion